Retraction notice to "An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients" [Journal of stroke and cerebrovascular diseases, volume 20, issue 1, 2011, pages 41-46]

We compile citations and summaries of about 400 new articles every week.

RSS Feed

HELP: Tutorials | FAQ

CONTACT US: Contact info

Search Results

Journal Article

Retraction notice to "An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients" [Journal of stroke and cerebrovascular diseases, volume 20, issue 1, 2011, pages 41-46]
Citation	Sato Y, Iwamoto J, Honda Y. J. Stroke Cerebrovasc. Dis. 2019; 28(11): e104426.
Affiliation	Department of Neurology, Mitate Hospital, Tagawa, Japan.
Copyright	(Copyright © 2019, National Stroke Association (U.S.A.), Publisher Elsevier Publishing)
DOI	10.1016/j.jstrokecerebrovasdis.2019.104426
PMID	31668218
Abstract	[Abstract unavailable] Language: en

NEW SEARCH
Download this record to:
RIS | BibTeX | EndNote

All SafetyLit records are available for automatic download to Zotero & Mendeley

Find full text at...